Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141239 |
| CAS No | NA |
| Mol.F. | C13H11N3O4 |
| Mol.Wt. | 273.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141240 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141241 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141242 |
| CAS No | NA |
| Mol.F. | C8H7N3O2S |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141243 |
| CAS No | NA |
| Mol.F. | C17H18N4O3S |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141244 |
| CAS No | NA |
| Mol.F. | C18H22N4O4S |
| Mol.Wt. | 390.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141245 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141246 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141247 |
| CAS No | NA |
| Mol.F. | C17H18N4O6S |
| Mol.Wt. | 406.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141248 |
| CAS No | NA |
| Mol.F. | C17H18N4O4 |
| Mol.Wt. | 342.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141249 |
| CAS No | NA |
| Mol.F. | C15H15FN4O4 |
| Mol.Wt. | 334.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141250 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O4 |
| Mol.Wt. | 376.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141251 |
| CAS No | NA |
| Mol.F. | C16H17FN4O2 |
| Mol.Wt. | 316.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141252 |
| CAS No | NA |
| Mol.F. | C17H18N4O5 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141253 |
| CAS No | NA |
| Mol.F. | C19H21N3O4S |
| Mol.Wt. | 387.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141254 |
| CAS No | NA |
| Mol.F. | C13H15BrN2O3 |
| Mol.Wt. | 327.2 |
| INV STATUS | CUSTOM SYNTHESIS |